Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
1.
J Oral Pathol Med ; 51(4): 315-321, 2022 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-35218247

RESUMEN

BACKGROUND: Sentinel lymph node biopsy is an increasingly recognised option for accurate staging and subsequent management of the clinically negative neck in early stage oral cavity squamous cell carcinoma. However, the technique is currently underused due to several logistic constraints including increased burden on pathology services. Here, we describe the feasibility of an outsourced centralised pathology processing and reporting service for sentinel lymph node biopsies in oral cavity squamous cell carcinoma. PATIENTS AND METHODS: The Southeast England Consortium comprises four surgical centres utilising a central pathology service. Consecutive cases between January 2016 and February 2020 were retrospectively evaluated for survival outcomes and laboratory turnaround times. RESULTS: Twenty-eight per cent from a cohort of 139 patients had positive sentinel nodes. There was a trend towards greater overall, disease-free and disease-specific survival (OS, DFS and DSS, respectively) in sentinel node negative compared to sentinel node positive patients, but these differences were not statistically significant. The sensitivity, negative predictive value and false negative rate were 92.8%, 97.0% and 6.8%, respectively. The mean and mode laboratory TAT were 5 and 4 working days, respectively. CONCLUSION: An outsourced centralised pathology service is a feasible option to widen the availability of sentinel node biopsy in oral cavity squamous cell carcinoma.


Asunto(s)
Carcinoma de Células Escamosas , Neoplasias de Cabeza y Cuello , Neoplasias de la Boca , Carcinoma de Células Escamosas/patología , Neoplasias de Cabeza y Cuello/patología , Humanos , Ganglios Linfáticos/patología , Metástasis Linfática/patología , Neoplasias de la Boca/patología , Estadificación de Neoplasias , Estudios Retrospectivos , Biopsia del Ganglio Linfático Centinela/métodos , Carcinoma de Células Escamosas de Cabeza y Cuello/patología
2.
Ir J Med Sci ; 189(3): 1039-1045, 2020 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-31811621

RESUMEN

BACKGROUND: Risk factors for advanced airway intervention among patients with dentofacial infection (DFI) are poorly understood. The appropriate delivery of clinical care to this patient group raises challenging anaesthetic service provision issues. The purpose of this study was to identify factors which may predict a requirement for an awake fibre optic intubation (AFOI) technique for airway management in this patient population. METHODS: A retrospective analysis of data for consecutive patients admitted with DFI were analysed at the Oral & Maxillofacial department at St James's Hospital, Dublin from July 2014-July 2015 was carried out. Receiver operating characteristic analysis determined optimal cut-off values predictive of AFOI, and multivariate logistic regression determined independent risk factors for AFOI. RESULTS: One hundred and twenty-five patients (64 male, 61 female) were admitted with DFI. The mean age was 35.9 years (range 16-91). AFOI was carried out in 58 (67.4%) patients who required GA. Increasing age was associated with an increase likelihood of AFOI (P = 0.047 95% CI 1.07(1.00-1.14). Reduced mouth opening was significantly associated with requirement for AFOI (28.8 ± 8.6 vs. 14.8 ± 8.6 mm, P < 0.0001). On receiver operating characteristic (ROC) analysis, mouth opening predicted requirement for AFOI with 87% accuracy (AUC 0.87 [95% CI 0.80-0.95], P < 0.0001). Using a cut-off value of 16.5 mm predicted subsequent AFOI with 96.7% (95% CI 78.1-100.0%) specificity and 65.6% (95% CI 51.4-77.8%) sensitivity. Initial C-reactive protein (CRP) was significantly associated with requirement for AFOI (60.1 ± 40.0 vs. 121.3 ± 89.8, P = 0.002). A CRP value of over 110 mg/L predicted subsequent AFOI with 95.8% (95% CI 78.9-100.0%) specificity. CONCLUSION: Increasing age, reduced mouth opening < 16.5 mm, and an increased serum admission CRP > 100 mg/L on admission significantly increase the requirement for AFOI on multivariate and univariate regression analysis. The availability of anaesthetists experienced in AFOI is essential for safe management of these patients.


Asunto(s)
Toma de Decisiones/fisiología , Deformidades Dentofaciales/etiología , Tecnología de Fibra Óptica/métodos , Intubación Intratraqueal/métodos , Adolescente , Adulto , Anciano , Anciano de 80 o más Años , Femenino , Humanos , Masculino , Persona de Mediana Edad , Estudios Retrospectivos , Vigilia , Adulto Joven
3.
Ir J Med Sci ; 188(1): 327-331, 2019 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-29700733

RESUMEN

Dentofacial infections (DFI) lead to morbidity and rarely, mortality. We hypothesised that certain clinical and laboratory parameter factors may be associated with a more severe course and an increased length of stay. We designed a prospective study that included all patients admitted with a DFI to the Oral and Maxillofacial Department between July 2014 and July 2015. A total of 125 were enrolled. We found that serum concentration of CRP on admission and increasing number of fascial spaces involved by the infection were significant predictors of hospital stay (p = 0.02 and p = 0.01, respectively). The average length of stay for a dentofacial infection requiring admission was 4.5 days. Most patients require surgical intervention in combination with intravenous antibiotics for successful resolution. Improved and timely access to primary dental care is likely to reduce the burden for patients their families and the acute hospital service as a consequence of advanced DFI.


Asunto(s)
Infección Focal Dental/cirugía , Adolescente , Adulto , Anciano , Anciano de 80 o más Años , Antibacterianos/uso terapéutico , Proteína C-Reactiva/metabolismo , Femenino , Infección Focal Dental/sangre , Infección Focal Dental/microbiología , Hospitalización , Humanos , Tiempo de Internación , Recuento de Leucocitos , Masculino , Persona de Mediana Edad , Atención Primaria de Salud , Estudios Prospectivos , Adulto Joven
4.
Gerodontology ; 34(4): 493-497, 2017 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-29094437

RESUMEN

OBJECTIVE: To present a case of spontaneous fracture of the genial tubercles of the mandible and a review of the literature. BACKGROUND: Resorption of the mandible is well documented in edentulous patients. During this process, the genial tubercles, origin for both genioglossus and geniohyoid muscles, become more prominent and prone to trauma especially from poorly fitted lower full dentures and lead to fracture and separation of the genial tubercles from the mandible. MATERIALS AND METHODS: An 85 year old patient with the above presentation was monitored and documented to present this case report. A literature search was carried out to identify any previous reports of this type of fracture, and their diagnosis and treatment modalities. RESULTS: This case is extremely rare with only 17 cases reported in the literature. CONCLUSION: Although rare, fractured genial tubercles should be considered in the differential diagnosis for a painful swelling in the floor of the mouth in the edentulous patient.


Asunto(s)
Fracturas Espontáneas/diagnóstico , Fracturas Mandibulares/diagnóstico , Anciano de 80 o más Años , Fracturas Espontáneas/patología , Fracturas Espontáneas/terapia , Humanos , Masculino , Mandíbula/patología , Fracturas Mandibulares/patología , Fracturas Mandibulares/terapia
5.
Artículo en Inglés | MEDLINE | ID: mdl-27544398

RESUMEN

Circumorificial plasmacytosis is a rare plasma cell proliferative disorder of the orificial mucous membranes. The etiology is unknown, and there are no reported effective treatments to date. We report three cases of idiopathic circumorificial plasmacytosis with varying clinical presentations and responses to treatment, including a first reported case of resolution with adalimumab therapy.


Asunto(s)
Adalimumab/uso terapéutico , Antiinflamatorios/uso terapéutico , Mucosa Bucal/patología , Mucositis/diagnóstico , Mucositis/tratamiento farmacológico , Células Plasmáticas/patología , Anciano , Biopsia , Femenino , Humanos , Masculino , Persona de Mediana Edad
6.
J Ir Dent Assoc ; 61(4): 196-200, 2015.
Artículo en Inglés | MEDLINE | ID: mdl-26506699

RESUMEN

AIM: This is a retrospective study to review the treatment and management of patients presenting with odontogenic infections in a large urban teaching hospital over a four-year period, comparing the number and complexity of odontogenic infections presenting to an acute general hospital in two periods, as follows: Group A (January 2008 to March 2010) versus Group B (April 2010 to December 2011). The background to the study is 'An alteration in patient access to primary dental care instituted by the Department of Health in April 2010'. OBJECTIVES: a) to identify any alteration in the pattern and complexity of patients' presentation with odontogenic infections following recent changes in access to treatment via the Dental Treatment Services Scheme (DTSS) and the Dental Treatment Benefit Scheme (DTBS) in April 2010; and, b) to evaluate the management of severe odontogenic infections. METHOD: Data was collated by a combination of a comprehensive chart review and electronic patient record analysis based on the primary discharge diagnosis as recorded in the Hospital In-Patient Enquiry (HIPE) system. RESULTS: Fifty patients were admitted to the National Maxillofacial Unit, St James's Hospital, under the oral and maxillofacial service over a four-year period, with an odontogenic infection as the primary diagnosis. There was an increased number of patients presenting with odontogenic infections during Group B of the study. These patients showed an increased complexity and severity of infection. Although there was an upward trend in the numbers and complexity of infections, this trending did not reach statistical significance. CONCLUSIONS: The primary cause of infection was dental caries in all patients. Dental caries is a preventable and treatable disease. Increased resources should be made available to support access to dental care, and thereby lessen the potential for the morbidity and mortality associated with serious odontogenic infections. The study at present continues as a prospective study.


Asunto(s)
Atención Odontológica/estadística & datos numéricos , Caries Dental/epidemiología , Servicio Odontológico Hospitalario/estadística & datos numéricos , Accesibilidad a los Servicios de Salud/estadística & datos numéricos , Atención Primaria de Salud/estadística & datos numéricos , Absceso/epidemiología , Adolescente , Adulto , Anciano , Anciano de 80 o más Años , Registros Electrónicos de Salud/estadística & datos numéricos , Femenino , Infección Focal Dental/epidemiología , Hospitales de Enseñanza , Humanos , Irlanda/epidemiología , Masculino , Persona de Mediana Edad , Enfermedades de la Boca/epidemiología , Admisión del Paciente/estadística & datos numéricos , Periodontitis/epidemiología , Estudios Retrospectivos , Enfermedades de las Glándulas Salivales/epidemiología , Odontología Estatal , Adulto Joven
7.
Artículo en Inglés | MEDLINE | ID: mdl-26340897

RESUMEN

Giant cell lesions (GCLs), previously referred to as giant cell granulomas, are benign tumors of the jaws of unknown etiology. Surgical management of aggressive GCLs is challenging, as these lesions demonstrate a tendency to recur following surgical removal. In addition, surgical treatment can be associated with significant morbidity. In an attempt to reduce both the extent of morbidity and the recurrence rate following surgery, a number of pharmacologic therapies have been advocated on the basis of assumptions about the predominant cell types and receptors, for the management of these lesions. This report describes the use of denosumab, an agent originally used for its anti-resorptive effects, in the management of an aggressive GCL of the mandible in an older patient, who was unsuitable for extensive surgery and in whom treatment with intralesional triamcinolone had proved unsuccessful. Denosumab may be a viable alternative or adjunct to surgery in the management of GCLs of the jaws.


Asunto(s)
Denosumab/uso terapéutico , Tumor Óseo de Células Gigantes/diagnóstico por imagen , Tumor Óseo de Células Gigantes/tratamiento farmacológico , Neoplasias Mandibulares/diagnóstico por imagen , Neoplasias Mandibulares/tratamiento farmacológico , Anciano de 80 o más Años , Biopsia , Conservadores de la Densidad Ósea/uso terapéutico , Calcio/uso terapéutico , Diagnóstico Diferencial , Femenino , Tumor Óseo de Células Gigantes/patología , Tumor Óseo de Células Gigantes/cirugía , Glucocorticoides/uso terapéutico , Humanos , Inyecciones Intralesiones , Neoplasias Mandibulares/patología , Neoplasias Mandibulares/cirugía , Uso Fuera de lo Indicado , Radiografía Panorámica , Tomografía Computarizada por Rayos X , Triamcinolona/uso terapéutico , Vitamina D/uso terapéutico
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA